Dr. Amy Wei-Hsin Laitinen, MD

Dr. Laitinen practices at Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida.

Dr. Laitinen's NPI, 1255863148, was assigned on March 30, 2017. Dr. Laitinen graduated from The Robert Larner, M.D. College of Medicine in 2017. Dr. Laitinen holds Florida license ME161096.

Dr. Laitinen's primary practice is Boca Raton Regional Hospital, at 800 Meadows Rd, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 955-4200.

Dr. Laitinen's primary practice is Boca Raton Regional Hospital in Boca Raton, Florida, part of Baptist Health South Florida. Dr. Laitinen is also affiliated with Bethesda Hospital East. The medical group on file is Baptist Health Medical Group North. Dmand AI also links Dr. Laitinen to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Laitinen practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Laitinen's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Laitinen is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Laitinen's licenses on file in 3 states: Florida, New York and Connecticut.

Dmand AI lists cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, migraine and chronic headache and multiple sclerosis among the conditions Dr. Laitinen treats.

CMS data shows 546 Medicare services from Dr. Laitinen across 11 procedure codes in 2024, for 212 Medicare patients. Medicare paid $47,050 for them.

CMS counts 212 Medicare patients who saw Dr. Laitinen in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Laitinen's median patient age at 59, with 77% women.

In 2024, Dr. Laitinen wrote 727 Medicare Part D claims for 116 patients. 72% of them were for generic drugs. CMS names the drug for 529 of them, across 21 drugs with 11 or more claims each, at $797,938 in total drug cost. In 2023, CMS named 210 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Laitinen for performance year 2024, reported through an alternative payment model (APM). Dr. Laitinen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Laitinen as offering telehealth.

CMS Open Payments shows 260 general payments to Dr. Laitinen from 19 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 52% of the total. Genentech, Inc. paid the most, $11,427. It also lists 1 research payment totaling $19 in 2025.

Dmand AI lists 8 awards for Dr. Laitinen, most recently CMSC National MS Society Scholarship in 2022.

Dr. Laitinen graduated from The Robert Larner, M.D. College of Medicine in 2017.

Dr. Laitinen is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.